全部 标题 作者
关键词 摘要

PLOS ONE  2013 

CT Air Trapping Is Independently Associated with Lung Function Reduction over Time

DOI: 10.1371/journal.pone.0061783

Full-Text   Cite this paper   Add to My Lib

Abstract:

Purpose We aimed to study the association between lung function decline and quantitative computed tomography (CT) air trapping. Materials and Methods Current and former heavy smokers in a lung cancer screening trial underwent volumetric low-dose CT in inspiration and expiration. Spirometry was obtained at baseline and after 3 years. The expiratory to inspiratory ratio of mean lung density (E/I-ratioMLD) was used to quantify air trapping. CT emphysema was defined as voxels in inspiratory CT below ?950 Hounsfield Unit. Linear mixed modeling was used to determine the association between CT air trapping and lung function. Results We included 985 subjects with a mean age of 61.3 years. Independent of CT emphysema, CT air trapping was significantly associated with a reduction in forced expiratory volume in one second (FEV1) and the ratio of FEV1 over the forced vital capacity (FEV1/FVC); FEV1 declines with 33 mL per percent increase in CT air trapping, while FEV1/FVC declines 0.58% per percent increase (both p<0.001). CT air trapping further elicits accelerated loss of FEV1/FVC (additional 0.24% reduction per percent increase; p = 0.014). Conclusion In a lung cancer screening cohort, quantitatively assessed air trapping on low-dose CT is independently associated with reduced lung function and accelerated decline of FEV1/FVC.

References

[1]  Mathers CD, Loncar D (2006) Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3(11): e442.
[2]  Murray CJ, Lopez AD (1997) Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study. Lancet 349(9064): 1498–1504.
[3]  Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, et al. (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6): 532–555.
[4]  Fletcher C, Peto R (1977) The natural history of chronic airflow obstruction. Br Med J 1(6077): 1645–1648.
[5]  Fiore MC, Baker TB (2011) Clinical practice. Treating smokers in the health care setting. N Engl J Med 365(13): 1222–1231.
[6]  Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, et al. (2011) Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365(5): 395–409.
[7]  Mets OM, Buckens CF, Zanen P, Isgum I, van Ginneken B, et al. (2011) Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. JAMA 306(16): 1775–1781.
[8]  Remy-Jardin M, Edme JL, Boulenguez C, Remy J, Mastora I, et al. (2002) Longitudinal follow-up study of smoker's lung with thin-section CT in correlation with pulmonary function tests. Radiology 222(1): 261–270.
[9]  Mohamed Hoesein FA, de Hoop B, Zanen P, Gietema H, Kruitwagen CL, et al. (2011) CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax 66(9): 782–787.
[10]  Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, et al. (2011) Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 365(13): 1184–1192.
[11]  Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, et al. (2012) Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 185(1): 44–52.
[12]  Yuan R, Hogg JC, Pare PD, Sin DD, Wong JC, et al. (2009) Prediction of the rate of decline in FEV(1) in smokers using quantitative Computed Tomography. Thorax 64(11): 944–949.
[13]  McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, et al. (2011) Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 365(17): 1567–1575.
[14]  van Iersel CA, de Koning HJ, Draisma G, Mali WP, Scholten ET, et al. (2007) Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 120(4): 868–874.
[15]  Miller MR, Crapo R, Hankinson J, Brusasco V, Burgos F, et al. (2005) General considerations for lung function testing. Eur Respir J 26(1): 153–161.
[16]  van Rikxoort EM, de Hoop B, Viergever MA, Prokop M, van Ginneken B (2009) Automatic lung segmentation from thoracic computed tomography scans using a hybrid approach with error detection. Med Phys 36(7): 2934–2947.
[17]  Schilham AM, van Ginneken B, Gietema H, Prokop M (2006) Local noise weighted filtering for emphysema scoring of low-dose CT images. IEEE Trans Med Imaging 25(4): 451–463.
[18]  O'Donnell RA, Peebles C, Ward JA, Daraker A, Angco G, et al. (2004) Relationship between peripheral airway dysfunction, airway obstruction, and neutrophilic inflammation in COPD. Thorax 59(10): 837–842.
[19]  Mets OM, Zanen P, Lammers JWJ, Isgum I, Gietema HA, et al. (2012) Early identification of small aiways disease on lung cancer screening CT: Comparison of current air trapping measures. Lung 190(6): 629–633.
[20]  Gevenois PA, De Maertelaer V, De Vuyst P, Zanen J, Yernault JC (1995) Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 152(2): 653–657.
[21]  Gevenois PA, De Vuyst P, de Maertelaer V, Zanen J, Jacobovitz D, et al. (1996) Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 154(1): 187–192.
[22]  Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, et al. (2008) A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 359(15): 1543–1554.

Full-Text

comments powered by Disqus